Učitavanje...
Neoadjuvant and adjuvant therapy for gastrointestinal stromal tumors
Gastrointestinal stromal tumors (GIST) are rare and mesenchymal in origin with a yearly incidence of 10‐15 cases per million people. If it is technically resectable, surgical resection is the mainstay of therapy regardless of tumor location,. Although complete (R0) resection can be achieved in up to...
Spremljeno u:
| Izdano u: | Ann Gastroenterol Surg |
|---|---|
| Glavni autori: | , , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
John Wiley and Sons Inc.
2018
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6345649/ https://ncbi.nlm.nih.gov/pubmed/30697609 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ags3.12211 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|